...
首页> 外文期刊>Revista Espaola de Enfermedades Digestivas >Efficacy and safety of ERCP in a low-volume hospital
【24h】

Efficacy and safety of ERCP in a low-volume hospital

机译:小剂量医院ERCP的疗效和安全性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background and aims: there is little scientific evidence on the outcomes of endoscopic retrograde cholangiopancreatography (ERCP) performed in low-volume hospitals; however, in our country, it is growing up its implementation. The objectives of our study were to evaluate the efficacy and safety of this technique performed by two endoscopists with basic training in a center of this nature and analyze the learning curve in the first procedures. Patients and methods: single-center retrospective study of the first 200 ERCP performed in our hospital (analyzing the evolution between the first 100 and 100 following procedures), comparing them with the quality standards proposed in the literature. Results: from February 2009 to April 2011, we performed 200 ERCP in 169 patients, and the most common indications were: Choledocholithiasis (77 %), tumors (14.5 %) and other conditions (8.5 %). The cannulation rate rose from 85 % in the first 100 ERCP to 89 % in the next 100 procedures, clinical success from 81 % to 87 %, decreasing the post-ERCP acute pancreatitis rate from 11 % to 4 %, upper gastrointestinal bleeding (UGIB) from 3 % to 2 % and acute cholangitis from 4 % to 1 %. There was a death from a massive UGIB in a cirrhotic patient in the first group of patients and a case of biliary perforation resolved by surgery in the second one. Conclusions: the results obtained after performing 200 procedures support the ability to practice ERCP in low-volume hospitals obtaining levels of efficacy and safety in accordance with published quality standards.
机译:背景和目的:在小容量医院进行内镜逆行胰胆管造影(ERCP)治疗的结果的科学证据很少;但是,在我们国家,它的实施正在不断发展。我们研究的目的是评估由两名内镜医师在这种性质的中心接受基础培训而实施的这项技术的有效性和安全性,并在第一步中分析学习曲线。患者和方法:在我院对前200例ERCP进行单中心回顾性研究(分析以下100例与100例之间的演变),并将其与文献中提出的质量标准进行比较。结果:从2009年2月到2011年4月,我们对169例患者进行了200次ERCP,最常见的适应症是:胆石症(77%),肿瘤(14.5%)和其他疾病(8.5%)。插管率从前100例ERCP中的85%上升至其后100例中的89%,临床成功率从81%降至87%,ERCP后急性胰腺炎的发生率从11%降低至4%,上消化道出血(UGIB )从3%到2%,急性胆管炎从4%到1%。在第一组患者中,肝硬化患者死于巨大的UGIB,在第二组患者中,通过手术解决了胆道穿孔。结论:执行200道手术后获得的结果支持在小批量医院中实践ERCP的能力,并根据公开的质量标准获得了疗效和安全性水平。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号